During the past decade, Spaarne Gasthuis conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 5 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spaarne Gasthuis" #1 sponsor was "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 8 trials, followed by "The Netherlands Cancer Institute" with 7 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 6 trials sponsored, "Amsterdam UMC, location VUmc" with 5 trials sponsored and "Pfizer" with 5 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spaarne Gasthuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 9 trials as a collaborator, "Erasmus Medical Center" with 5 trials as a collaborator, "Leiden University Medical Center" with 5 trials as a collaborator, "Boehringer Ingelheim" with 4 trials as a collaborator and "Borstkanker Onderzoek Groep" with 4 trials as a collaborator. Other collaborators include 146 different institutions and companies that were collaborators in the rest 118 trials.

According to Clinical.Site data, the most researched conditions in "Spaarne Gasthuis" are "Breast Cancer" (6 trials), "Colorectal Cancer" (4 trials), "Atrial Fibrillation" (3 trials), "Heart Failure" (3 trials) and "Acute Respiratory Failure" (2 trials). Many other conditions were trialed in "Spaarne Gasthuis" in a lesser frequency.

Most popular intervention types in "Spaarne Gasthuis" are "Drug" (43 trials), "Other" (13 trials), "Procedure" (13 trials), "Biological" (6 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Nivolumab" (2 trials), "Usual Care" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "radiotherapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Spaarne Gasthuis" are 70 trials for "All" genders and 11 trials for "Female" genders.

Currently, there are NaN active trials in "Spaarne Gasthuis". undefined are not yet recruiting, 24 are recruiting, 9 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 32 completed trials in Spaarne Gasthuis, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Spaarne Gasthuis, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 14 trials that are defined as “Not Applicable".